Bioverativ Inc. 4/A SEC Filings

Filed On	Filing
27 Mar 2017	Form 4/A: Duvall Diantha, Chief Accounting Officer Granted 11,062 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Greene John, EVP, CFO and Treasurer Granted 169,845 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: DiFabio Andrea, EVP, Chief Legal Officer Granted 119,189 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Cox John, Director Granted 581,049 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Vivaldi Coelho Rogerio, EVP, Chief Global Therapeutics Granted 169,845 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Brudnick Richard, EVP, Business Development Granted 104,291 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Celona Lucia, EVP, HR & Corp Commun. Officer Granted 104,291 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Paglia Louis J, Director Granted 26,818 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Denner Alexander J, Director Granted 26,818 Non-Qualified Stock Option
27 Mar 2017	Form 4/A: Posner Brian S, Director Granted 29,798 Non-Qualified Stock Option

Comments